Last reviewed · How we verify

Cyclorin — Competitive Intelligence Brief

Cyclorin (CYCLOSERINE) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: cycloserine. Area: Infectious Disease.

marketed cycloserine Glutamate receptor ionotropic, NMDA 2A Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Cyclorin (CYCLOSERINE) — Purdue Gmp.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Cyclorin TARGET CYCLOSERINE Purdue Gmp marketed cycloserine Glutamate receptor ionotropic, NMDA 2A 1964-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (cycloserine class)

  1. Purdue Gmp · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cyclorin — Competitive Intelligence Brief. https://druglandscape.com/ci/cycloserine. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: